Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
Filing tables
Filing exhibits
Related press release
IMVT similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statement of Immunovant, Inc.:
(1) Registration Statement (FormS-8No. 333-236665) pertaining to the Immunovant, Inc. 2019 Equity Incentive Plan and the Immunovant Sciences Ltd. 2018 Equity Incentive Plan;
of our report dated June 29, 2020, with respect to the combined and consolidated financial statements of Immunovant, Inc. included in this Annual Report (Form10-K) of Immunovant, Inc. for the year ended March 31, 2020.
/s/ Ernst & Young LLP
Iselin, New Jersey
June 29, 2020